Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 814

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Biodegradation and biocompatibility of PLA and PLGA microspheres

Anderson, James M., Shive, Matthew S.·2012·Advanced Drug Delivery Reviews
DOI 10.1016/j.addr.2012.09.004
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2012.09.004

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 64

  1. Anderson, 1994, In vivo biocompatibility of implantable delivery systems and biomaterials, Eur. J. Pharm. Biopharm., 40, 1
  2. Anderson, 1993, Mechanisms of inflammation and infection with implanted devices, Cardiovasc. Pathol., 2, 33S, 10.1016/1054-8807(93)90045-4 · DOI · Paper page
  3. Anderson, 1994, Inflammation and the foreign body response, Probl. Gen. Surg., 11, 147
  4. Okada, 1995, Biodegradable microspheres in drug delivery, Crit. Rev. Ther. Drug Carrier Syst., 12, 1, 10.1615/CritRevTherDrugCarrierSyst.v12.i1.10 · DOI · Paper page
  5. Schakenraad, 1990, Enzymatic activity toward poly(L-lactic acid) implants, J. Biomed. Mater. Res., 24, 529, 10.1002/jbm.820240502 · DOI
  6. Spenlehauer, 1989, In vitro and in vivo degradation of poly(DL- lactide/glycolide) type microspheres made by solvent evaporation method, Biomaterials, 10, 557, 10.1016/0142-9612(89)90063-X · DOI · Paper page
  7. Vert, 1994, Biodegradation of PLA/GA polymers: increasing complexity, Biomaterials, 15, 1209, 10.1016/0142-9612(94)90271-2 · DOI · Paper page
  8. Grizzi, 1995, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials, 16, 305, 10.1016/0142-9612(95)93258-F · DOI · Paper page
  9. Vert, 1994, Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids, J. Biomater. Sci. Polym. Ed., 6, 639, 10.1163/156856294X00581 · DOI
  10. Vert, 1995, Recent advances in the field of lactic acid/glycolic acid polymer-based therapeutic systems, Macromol. Symp., 98, 633, 10.1002/masy.19950980154 · DOI
  11. Visscher, 1985, Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules, J. Biomed. Mater. Res., 19, 349, 10.1002/jbm.820190315 · DOI · Paper page
  12. Visscher, 1986, Note: Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules, J. Biomed. Mater. Res., 20, 667, 10.1002/jbm.820200510 · DOI
  13. Visscher, 1987, Tissue response to biodegradable injectable microcapsules, J. Biomater. Appl., 2, 118, 10.1177/088532828700200103 · DOI
  14. Visscher, 1988, Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsules, J. Biomed. Mater. Res., 22, 733, 10.1002/jbm.820220806 · DOI
  15. Tabata, 1988, Macrophage phagocytosis of biodegradable microspheres composed of l-lactic acid/glycolic acid homo- and copolymers, J. Biomed. Mater. Res., 22, 837, 10.1002/jbm.820221002 · DOI · Paper page
  16. Tabata, 1989, Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation, Pharm. Res., 6, 296, 10.1023/A:1015942306801 · DOI
  17. Tabata, 1990, Phagocytosis of polymer microspheres by macrophages, Adv. Polym. Sci., 94, 107, 10.1007/BFb0043062 · DOI · Paper page
  18. Maulding, 1986, Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament, J. Control. Release, 3, 103, 10.1016/0168-3659(86)90071-4 · DOI
  19. Pistner, 1993, Poly(L-lactide): a long-term degradation study in vivo Part III. Analytical characterization, Biomaterials, 14, 291, 10.1016/0142-9612(93)90121-H · DOI · Paper page
  20. Bostman, 1990, Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers, J. Bone Joint Surg. Br., 72B, 592, 10.1302/0301-620X.72B4.2199452 · DOI · Paper page
  21. Bergsma, 1993, Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for fixation of unstable zygomatic fractures, J. Oral Maxillofac. Surg., 51, 666, 10.1016/S0278-2391(10)80267-8 · DOI · Paper page
  22. F.R. Rozema, Resorbable poly(l-lactide) bone plates and screws: Tests and applications. Academisch Ziekenhuis Groningen, Afdeling Mondziektenen Kaakchirurgie-Ill. Thesis, Groningen University, 1991.
  23. Isobe, 1996, Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer, J. Biomed. Mater. Res., 32, 433, 10.1002/(SICI)1097-4636(199611)32:3<433::AID-JBM17>3.0.CO;2-H · DOI
  24. Kamei, 1992, New method for analysis of biodegradable polyesters by high-performance liquid chromatography after alkali hydrolysis, Biomaterials, 13, 953, 10.1016/0142-9612(92)90120-D · DOI
  25. Heya, 1994, In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(DL-lactic/glycolic acid) microspheres, J. Pharm. Sci., 83, 636, 10.1002/jps.2600830508 · DOI
  26. McNally, 1995, Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells, Am. J. Pathol., 147, 1487
  27. Yamaguchi, 1993, In vivo biocompatibility studies of medisorb® 65/35 dl-lactide/glycolide copolymer microspheres, J. Control. Release, 24, 81, 10.1016/0168-3659(93)90169-6 · DOI
  28. Yamaguchi, 1992, Biocompatibility studies of naltrexone sustained release formulations, J. Control. Release, 19, 299, 10.1016/0168-3659(92)90085-6 · DOI
  29. Spilizewski, 1985, The effect of hydrocortisone acetated loaded poly(dl-lactide) films on the inflammatory response, J. Control. Release, 2, 197, 10.1016/0168-3659(85)90045-8 · DOI
  30. Ike, 1992, Controlled cisplatin delivery system using poly(dl-lactic acid), Biomaterials, 13, 230, 10.1016/0142-9612(92)90189-U · DOI
  31. Itoi, 1996, In vivo suppressive effects of copoly(glycolic/L-lactic acid) microspheres containing CDDP on murine tumor cells, J. Control. Release, 42, 175, 10.1016/0168-3659(96)01454-X · DOI
  32. Curley, 1996, Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres, Anesthesiology, 84, 1401, 10.1097/00000542-199606000-00017 · DOI · Paper page
  33. Smith, 1986, Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration, Int. J. Pharm., 30, 215, 10.1016/0378-5173(86)90081-5 · DOI · Paper page
  34. Kenley, 1994, Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2), J. Biomed. Mater. Res., 28, 1139, 10.1002/jbm.820281004 · DOI · Paper page
  35. Lee, 1994, Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix, J. Biomed. Mater. Res., 28, 1149, 10.1002/jbm.820281005 · DOI · Paper page
  36. Saitoh, 1994, Effect of polylactic acid on osteoinduction of demineralized bone: preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein, J. Oral Rehabil., 21, 431, 10.1111/j.1365-2842.1994.tb01157.x · DOI
  37. Mayer, 1996, Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier, Plast. Reconstr. Surg., 98, 247, 10.1097/00006534-199608000-00006 · DOI
  38. Turk, 1993, Enhanced healing of large cranial defects by an osteoinductive protein in rabbits, Plast. Reconstr. Surg., 92, 593, 10.1097/00006534-199309001-00006 · DOI
  39. Hollinger, 1996, Poly(α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration, J. Control. Release, 39, 287, 10.1016/0168-3659(95)00183-2 · DOI
  40. Hollinger, 1996, Role of bone substitutes, Clin. Orthop. Relat. Res., 324, 55, 10.1097/00003086-199603000-00008 · DOI · Paper page
  41. Hollinger, 1996, Poly(α-hydroxy acids): carriers for bone morphogenetic proteins, Biomaterials, 17, 187, 10.1016/0142-9612(96)85763-2 · DOI · Paper page
  42. Winet, 1995, Incorporation of polylactide-polyglycolide in a cortical defect: neoangiogenesis and blood supply in a bone chamber, J. Orthop. Res., 13, 679, 10.1002/jor.1100130507 · DOI
  43. Ogura, 1995, Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium, Surv. Ophthalmol., 39, S-17, 10.1016/S0039-6257(05)80069-4 · DOI
  44. Ogawa, 1988, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers, Chem. Pharm. Bull., 36, 2576, 10.1248/cpb.36.2576 · DOI · Paper page
  45. Menei, 1993, Biodegradation and brain tissue reaction to poly(dl-lactide-co-glycolide) microspheres, Biomaterials, 14, 470, 10.1016/0142-9612(93)90151-Q · DOI · Paper page
  46. McRae, 1994, Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats, Mol. Neurobiol., 9, 191, 10.1007/BF02816119 · DOI
  47. McRae, 1992, Dopamine fiber growth induction by implantation of synthetic dopamine-containing microspheres in rats with experimental hemi-Parkinsonism, Mol. Chem. Neuropathol., 16, 123, 10.1007/BF03159965 · DOI
  48. Gref, 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245 · DOI · Paper page
  49. Allémann, 1993, Drug-loaded nanoparticles – preparation methods and drug targeting issues, Eur. J. Pharm. Biopharm., 39, 173
  50. Allémann, 1995, PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours, J. Pharm. Pharmacol., 47, 382, 10.1111/j.2042-7158.1995.tb05815.x · DOI
  51. Allémann, 1996, Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles, Int. J. Cancer, 66, 821, 10.1002/(SICI)1097-0215(19960611)66:6<821::AID-IJC19>3.0.CO;2-5 · DOI
  52. Leroux, 1995, An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(dl-lactic acid) nanoparticles by human monocytes, Life Sci., 57, 695, 10.1016/0024-3205(95)00321-V · DOI
  53. E. Allémann, P. Gravel, J.-C. Leroux, L. Balant, R. Gurny, Kinetics of blood components adsorption on poly(dl-lactic acid) nanoparticles – evidence of complement C3 component involvement. J. Biomed. Mater. Res. (in press).
  54. Fernández-Urrusuno, 1996, Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice, J. Biomed. Mater. Res., 31, 401, 10.1002/(SICI)1097-4636(199607)31:3<401::AID-JBM15>3.0.CO;2-L · DOI
  55. Fernández-Urrusuno, 1995, Influence of surface properties on the inflammatory response to polymeric nanoparticles, Pharm. Res., 12, 1385, 10.1023/A:1016246312350 · DOI
  56. Ronneberger, 1997, Biocompatibility of ABA triblock copolymer microparticles consisting of poly(l-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection, Eur. J. Pharm. Biopharm., 43, 19, 10.1016/S0939-6411(96)00006-9 · DOI
  57. Gref, 1995, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres, Adv. Drug Deliv. Rev., 16, 215, 10.1016/0169-409X(95)00026-4 · DOI · Paper page
  58. Ronneberger, 1996, In vivo biocompatibility study of ABA triblock copolymers consisting of poly(l-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks, J. Biomed. Mater. Res., 30, 31, 10.1002/(SICI)1097-4636(199601)30:1<31::AID-JBM5>3.0.CO;2-S · DOI
  59. Ermak, 1995, Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells, Cell Tissue Res., 279, 433, 10.1007/BF00318501 · DOI
  60. Eldridge, 1990, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches, J. Control. Release, 11, 205, 10.1016/0168-3659(90)90133-E · DOI · Paper page
  61. Eldridge, 1989, Biodegradable microspheres: vaccine delivery system for oral immunization, Curr. Top. Microbiol. Immunol., 146, 59
  62. Eldridge, 1991, Biodegradable microspheres as a vaccine delivery system, Mol. Immunol., 28, 287, 10.1016/0161-5890(91)90076-V · DOI · Paper page
  63. Eldridge, 1991, Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for Staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect. Immun., 59, 2978, 10.1128/IAI.59.9.2978-2986.1991 · DOI · Paper page
  64. Thomasin, 1996, Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response, J. Control. Release, 41, 131, 10.1016/0168-3659(96)01363-6 · DOI · Paper page

Cited by

See all 814

Metadata

Authors
Anderson, J. M., & Shive, M. S.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2012-12
Volume
64
Pages
72-82
ISSN
0169-409X (ISSN-L)
DOI
10.1016/j.addr.2012.09.004
OpenAlex
W4251960546
Cited by
814
References
2
FWCI
5.90
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biodegradation and biocompatibility of PLA and PLGA microspheres. https://app.cochat.ai/papers/10.1016/j.addr.2012.09.004
The paper
Anderson, J. M., & Shive, M. S. (2012). Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2012.09.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.